SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
13-D SC 13G/A 2/14/2020
13-D SC 13G/A 2/14/2020
8-K 8-K 2/6/2020 2/2/2020
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 1/13/2020 1/7/2020
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Financial Statements and Exhibits.
13-D SC 13G/A 1/9/2020
Prospectus 424B3 12/30/2019
8-K 8-K 12/20/2019 12/17/2019
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
13-D SC 13G 12/20/2019
Registration Statement S-1 12/20/2019
Registration Statement D 12/17/2019
8-K 8-K 12/13/2019 12/11/2019
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Disclosure; and Financial Statements and Exhibits.
Prospectus 424B5 12/13/2019
8-K 8-K 12/11/2019 12/11/2019
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing and Other Events.
8-K 8-K 12/10/2019 12/10/2019
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K 8-K 12/10/2019 12/10/2019
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Regulation FD Disclosure and Financial Statements and Exhibits.
13-D SC 13G 11/25/2019
8-K 8-K 11/19/2019 11/19/2019
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 11/15/2019 11/15/2019
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Other Events and Financial Statements and Exhibits.
Prospectus 424B4 11/15/2019
8-K 8-K 11/13/2019 11/13/2019
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Entry into a Material Definitive Agreement; Other Events; and Financial Statements and Exhibits.

Displaying 1 to 20 (of 154 filings)